Manufacturer of Lanoxin tablet 0.25 mg
Lanoxin tablet is manufactured by GlaxoSmithKline Pharmaceutical Ltd.
Content of Lanoxin tablet 0.25 mg
Lanoxin tablet contains digoxin ,it is a cardiac glycoside .And
also known as cardiotonic,increases the strength of cardiac muscle contractions
and increases cardiac output.In mild heart failure ,digoxin inhibits the
sympathetic nervous system and produces arterial vasodilation.It produces
symptomatic improvement,increases exercise tolerance and reduces hospitalization,
but it does not reduce mortality.
Uses of Lanoxin tablet 0.25 mg
- Supraventricular arrhythmias
- Atrial fibrillation
- Emergency heart failure
Contraindications of Lanoxin tablet 0.25 mg
- Hypertrophic obstructive cardiomyopathy
- Ventricular tachycardia
- Hypokalaemia
- Digitalis toxicity
- Arrhythmias
- Second degree atrioventricular block
- Wolff-Parkinson-White syndrome (A syndrome in which an extra
electrical pathway in the heart causes a rapid heartbeat)
Precautions of Lanoxin tablet
0.25 mg
- Recent myocardial
- Sick sinus syndrome
- Severe pulmonary disease
- Thyroid disease
- Congestive cardiac myopathy
- Hypercalcaemia
- Aortic valve disease
- Heart block
- Cardiac
- Elderly (reduce dose)
- Renal impairment
- Pregnancy
- Lactation
Usually
associated with excessive dosage and include
- Anorexia
- Nausea
- Vomiting
- Diarrhoea
- Abdominal pain
- Visual disturbances
- Head ache
- Fatigue
- Drowsiness
- Confusion
- Delirium
- Hallucinations
- Depression
- Arrhythmias
- Heart block
- Skin rashes
- Intestinal ischemia
- Gynaecomastia on long term use
- Thrombocytopenia reported
- Sinus bradycardia
- Apathy
- Psychosis
If any of
the event occurred please contact your concerned doctor .
Pregnancy category –D
There is positive evidence of human fetal risk based on adverse
reaction data from investigational or marketing experience or studies in
humans, but potential benefits may warrant use of the drug in pregnant
women despite potential risks.
0 comments:
Post a Comment